Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    80.00 (1.63%)
Bid:
5,000.00
Ask:
5,050.00
Spread: 50.00 (1.00%)
Market Cap: £333.03m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Total Voting Rights

1 Apr 2019 12:35

RNS Number : 6972U
Judges Scientific PLC
01 April 2019
 

Press Release

 

 

Judges Scientific plc

 

("Judges Scientific")

 

Total Voting Rights

 

Judges Scientific confirms that, as at 1 April 2019, the total issued share capital has increased to 6,200,308 ordinary shares of 5p each ("Ordinary Share").

 

There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,200,308 Ordinary Shares.

 

The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.

 

- Ends -  

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export.

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAFLFEDFNEFF
Date   Source Headline
16th Mar 20062:25 pmRNSNotice of Preliminary Results
28th Feb 200611:42 amRNSAdditional Listing
23rd Feb 20066:15 pmRNSDirector/PDMR Shareholding
22nd Feb 20067:01 amRNSAcquisition
24th Nov 20057:01 amRNSClarification of Holding
16th Nov 200510:55 amRNSHolding(s) in Company
24th Oct 200512:03 pmRNSAppointment of Director
27th Sep 20057:01 amRNSDirector/PDMR Shareholding
15th Sep 20057:01 amRNSInterim Results
5th Sep 20051:25 pmRNSAcquisition
17th Jun 20055:22 pmRNSHolding(s) in Company
27th May 20057:00 amRNSHolding(s) in Company
23rd May 20055:20 pmRNSResult of EGM
6th May 200510:43 amRNSSchedule 1 - Judges Capital
29th Apr 20057:02 amRNSAcquisition and Placing
29th Apr 20057:02 amRNSFinal Results and Acquisition
14th Jan 20058:38 amRNSHolding(s) in Company
10th Jan 20059:30 amRNSSale of investment
10th Jan 20059:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.